Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Doximity ( (DOCS) ) is now available.
On August 13, 2025, Doximity announced that its General Counsel, Corporate Secretary, and Chief Compliance Officer, Jennifer Chaloemtiarana, will step down from her roles effective August 29, 2025, with John Vaughan taking over these positions. Chaloemtiarana will continue in an advisory role until November 17, 2025, after which she will receive post-employment benefits as per her offer letter.
The most recent analyst rating on (DOCS) stock is a Hold with a $58.00 price target. To see the full list of analyst forecasts on Doximity stock, see the DOCS Stock Forecast page.
Spark’s Take on DOCS Stock
According to Spark, TipRanks’ AI Analyst, DOCS is a Outperform.
Doximity’s overall stock score is driven by its strong financial performance and positive earnings call, which highlight robust growth and strategic advancements in AI. While technical indicators show a positive trend, the high P/E ratio suggests potential overvaluation, slightly tempering the overall score.
To see Spark’s full report on DOCS stock, click here.
More about Doximity
Doximity operates in the healthcare industry, providing a professional network platform for medical professionals, focusing on enhancing communication and collaboration among healthcare providers.
Average Trading Volume: 2,275,035
Technical Sentiment Signal: Buy
Current Market Cap: $11.91B
Learn more about DOCS stock on TipRanks’ Stock Analysis page.